Buy Carb-DNA Carboplatin

Carb-DNA (Carboplatin) 450mg/45ml vials are a platinum-based chemotherapy medication used for cancer treatment. This injectable solution targets rapidly dividing cells to help manage various cancers. Suitable for patients requiring chemotherapy under medical supervision.

Strength

450mg/45ml

Manufacturer / TM Owner

Beta Drugs Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Carboplatin is primarily used to treat ovarian cancer, lung cancer, head and neck cancers, and other solid tumors. It may also be prescribed for bladder cancer or as part of combination therapies. Patients often ask, 'what is Carboplatin used for' when discussing treatment options with healthcare providers. This medication works by interfering with DNA replication in cancer cells.

Side Effects

Carboplatin may cause side effects such as nausea, vomiting, or fatigue, which are commonly managed with supportive care. Some patients experience changes in blood cell counts, leading to increased infection risk or fatigue. Hair loss is another possible effect during treatment cycles.

Precautions & Warnings

Carboplatin should only be administered under medical supervision by healthcare professionals experienced in chemotherapy. Patients must undergo regular blood tests to monitor bone marrow function and kidney health. Hydration before and after treatment helps reduce kidney-related side effects.

Avoid Interactions

Carboplatin may interact with other medications affecting bone marrow or kidney function, including certain antibiotics or diuretics. Combining it with nephrotoxic drugs could increase kidney stress. Alcohol use may exacerbate side effects like nausea or dizziness. Always disclose all medications to your healthcare provider.

References

Frequently Asked Questions

Carboplatin is used to treat various cancers, including ovarian, lung, and head and neck cancers, often in combination with other chemotherapy drugs.

Carboplatin is given as an intravenous infusion by healthcare professionals in a clinical setting.

Yes, hair loss is a possible side effect of Carboplatin chemotherapy, though it varies by patient.

Carboplatin may harm unborn babies; discuss risks and alternatives with your doctor if pregnant or planning pregnancy.

Common side effects include nausea, vomiting, fatigue, and changes in blood cell counts.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.